Synthesis of some new benzisothiazolone and benzenesulfonamide derivatives of biological interest starting from saccharin sodium

Archiv der Pharmazie

Volumn 346, Issue 10, 2013, Pages 733-742

  El Sabbagh, Osama I ^a,b  

^a TAIF UNIVERSITY   (Saudi Arabia)

^b Zagazig University   (Egypt)

Author keywords

Antiviral activity; Benzenesulfonamide; Benzisothiazolone derivatives; Saccharin sodium; Synthesis

Indexed keywords

2 (2 (4 BROMOBENZYLIDENE)HYDRAZINECARBONYL) N ISOPROPYLBENZENESULFONAMIDE; 2 (2 (4 CHLOROBENZOYL)HYDRAZINECARBONYL) N ISOPROPYLBENZENESULFONAMIDE; 2 (2 (4 FLUOROBENZYLIDENE)HYDRAZINECARBONYL) N ISOPROPYLBENZENESULFONAMIDE; 2 (2 BENZYLIDENEHYDRAZINECARBONYL) N ISOPROPYLBENZENESULFONAMIDE; 2 [N (2,5 DIMETHYLPHENYL)ACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; 2 [N (4 (1 ( (4 (4 BROMOPHENYL)THIAZOL 2(3H) YLIDENE) HYDRAZONO)ETHYL)PHENYL)ACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; 2 [N (4 (1 (2 CARBAMOTHIOYLHYDRAZONO)ETHYL)PHENYL) ACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; 2 [N (4 (1 (4 (4 CHLOROPHENYL)THIAZOL 2(3H) YLIDENE) HYDRAZONO)ETHYL)PHENYLACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; 2 [N (4 (1 (4 (4 METHYLPHENYL)THIAZOL 2(3H) YLIDENE) HYDRAZONO)ETHYL)PHENYL)ACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; 2 [N (4 (1 (4 (PHENYL)THIAZOL 2(3H) YLIDENE)HYDRAZONO) ETHYL)PHENYL)ACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; 2 [N (4 (N ACETYLSULFAMOYL)PHENYL)ACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; 2 [N (4 ACETYLPHENYL)ACETAMIDO] 1,2 BENZISOTHIAZOL 3(2H) ONE 1,1 DIOXIDE; BENZISOTHIAZOLONE DERIVATIVE; DENZENESULFONAMIDE DERIVATIVE; N ISOPROPYL 2 (2 (4 METHOXYBENZYLIDENE) HYDRAZINECARBONYL)BENZENESULFONAMIDE; N ISOPROPYL 2 (2 (4 METHYLBENZYLIDENE) HYDRAZINECARBONYL)BENZENESULFONAMIDE; N ISOPROPYL 2 (2 (THIOPHEN 2 YLMETHYLENE)HYDRAZINECARBONYL)BENZENESULFONAMIDE; N ISOPROPYL 2 (2 TOSYLHYDRAZINECARBONYL) BENZENESULFONAMIDE; N ISOPROPYL 2 (5 (METHYLTHIO) 1,3,4 OXADIAZOL 2 YL) BENZENESULFONAMIDE; N ISOPROPYL 2 (5 MERCAPTO 1,3,4 OXADIAZOL 2 YL) BENZENESULFONAMIDE; SACCHARIN SODIUM; SULFONAMIDE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CYTOMEGALOVIRUS; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS STRAIN;

ANTIVIRAL ACTIVITY; BENZENESULFONAMIDE; BENZISOTHIAZOLONE DERIVATIVES; SACCHARIN SODIUM; SYNTHESIS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; HUMANS; LUNG; MICE; SACCHARIN; SPECTRUM ANALYSIS; SULFONAMIDES; THIAZOLES; VIRUSES;

EID: 84885630828     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201300110     Document Type: Article

References (26)

1. H. Goker, C. Kus, D. W. Boykin, S. Yildiz, N. Altanlar, Bioorg. Med. Chem. 2002, 10, 2589-2596.
2. R. J. Whitley, B. Roizman, Lancet 2001, 357, 1513-1518.
3. K. S. Gudmundsson, B. A. Johns, S. H. Allen, Bioorg. Med. Chem. Lett. 2008, 18, 1157-1161.
4. O. I. El-Sabbagh, M. M. Baraka, S. M. Ibrahim, C. Pannecouque, G. Andrei, R. Snoeck, J. Balzarini, A. A. Rashad, Eur. J. Med. Chem. 2009, 44, 3746-3753.
5. A. A. Rashad, O. I. El-Sabbagh, M. M. Baraka, S. M. Ibrahim, C. Pannecouque, G. Andrei, R. Snoeck, J. Balzarini, A. Mostafa, Med. Chem. Res. 2010, 19, 1025-1035.
6. C. Romanutti, V. Castilla, C. E. Coto, M. B. Wachsman, Int. J. Antimicrob. Agents 2007, 29, 311-316.
7. J. Balzarini, M. Baba, E. De Clercq, Antimicrob. Agents Chemother. 1995, 39, 998-1002.
8. R. F. Schinazi, B. A. Larder, J. W. Mellors, Int. Antiviral News 1997, 5, 129-142.
9. M. S. Novikov, V. T. Valuev-Elliston, D. A. Babkov, M. P. Paramonova, A. V. Ivanov, S. A. Gavryushov, A. L. Khandazhinskaya, S. N. Kochetkov, C. Pannecouque, G. Andrei, R. Snoeck, J. Balzarini, K. L. Seley-Radtke, Bioorg. Med. Chem. 2013, 21, 1150-1158.
10. A. E. Rashad, M. I. Hegab, R. E. Abdel-Megeid, J. A. Micky, F. M. Abdel-Megeid, Bioorg. Med. Chem. 2008, 16, 7102-7106.
11. L. Zeng, H. Zhang, Y. Wang, T. Sanchez, Y. Zheng, N. Neamati, Y. Long, Bioorg. Med. Chem. Lett. 2008, 18, 4521-4524.
12. J. J. Crute, C. A. Grygon, K. D. Hargrave, B. Simoneau, A. M. Faucher, G. Bolger, P. Kiber, M. Liuzzi, M. G. Cordingley, Nat. Med. 2002, 8, 386-391.
13. F. Poordad, E. Lawitz, K. V. Kowdley, D. E. Cohen, T. Podsadecki, S. Siggelkow, M. Heckaman, L. Larsen, R. Menon, G. Koev, R. Tripathi, T. Pilot-Matias, B. Bernstein, N. Engl. J. Med. 2013, 368, 45-53.
14. T. Syed, T. Akhtar, N. A. Al-Masoudi, P. G. Jones, S. Hameed, J. Enz. Inhib. Med. Chem. 2011, 26, 668-680.
15. R. Iqbal, M. Zareef, S. Ahmed, J. H. Zaidi, M. Arfan, M. Shafique, N. A. Al-Masoudi, J. Chin. Chem. Soc. 2006, 53, 689-696.
16. R. C. Ogden, C. W. Flexner, Eds. Protease Inhibitors in AIDS Therapy, Marcel Dekker, New York, Basel 2001.
17. M. C. Boily, R. F. Baggaley, L. Wang, B. Masse, R. G. White, R. J. Hayes, M. Alary, Lancet Infect. Dis. 2009, 9, 118-129.
18. M. I. Al-Ashmawi, L. A. Abdel-Aziz, S. Mustafa, Zag. J. Pharm. Sci. 1999, 8, 47-52.
19. E. H. Abdel Aal, O. I. El-Sabbagh, S. Youssif, S. M. El-Nabtity, Monatsh. Chem. 2002, 133, 255-266.
20. Y. V. Svetkin, Zh. Obshch. Khim. 1961, 31, 2023-2025.
21. M. A. Al-Sha'er, M. O. Taha, Med. Chem. Res. 2012, 21, 487-510.
22. T. Gazivoda, S. Raic̈-Malic̈, M. Marjanovic̈, M. Kralj, K. Pavelic̈, J. Balzarini, E. De Clercq, M. Mintas, Bioorg. Med. Chem. 2007, 15, 749-758.
23. R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter, E. De Clercq, J. Virol. Methods 1988, 20, 309-321.
24. A. Montagu, V. Roy, J. Balzarini, R. Snoeck, G. Andrei, L. A. Agrofoglio, Eur. J. Med. Chem. 2011, 46, 778-786.
25. E. De Clercq, Antiviral Res. 2005, 67, 56-75.
26. R. Pauwels, Curr. Opin. Pharmacol. 2004, 4, 437-446.